Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2486 participants.

Also called NCT02089217

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 2,486 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02089217
Other papers using this trial's data
  • Medical Management and Revascularization for Asymptomatic Carotid Stenosis The New England journal of medicine, 2026-01-15 DOI, PubMed 41269206, PMC13148431 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Australia, Canada, Israel, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02089217. Randomized; single masking; primary purpose prevention. Start 2014-12-09 (actual); primary completion 2025-09-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Acronym
CREST-2
Condition
Carotid Stenosis
Intervention (Procedure)
Carotid endarterectomy (CEA)
Intervention (Device)
Carotid Stenting (CAS)
Intervention (Other)
Intensive Medical Management - no CEA
Intervention (Other)
Intensive Medical Management - no CAS
Lead sponsor
Mayo Clinic (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02089217
Content hash
1971e67b6da169cbb02037c158655d9f0af8a4ed669cef4a27e7c6f9662ef7e9